Patent · US Active

Gene expression markers for colorectal cancer prognosis

US7695913B2 · kind B2 · utility

34Cited by
0References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 11, 2007
Grant dateApr 13, 2010
Priority date
Expiry dateSep 4, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/118
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.